EODData

MEMBERSHIP REGISTER LOG IN

FRA, H2K2: XTL Biopharmaceuticals Ltd

03 Sep 2025
LAST:

0.9650

CHANGE:
 0.01		OPEN:
0.9750		HIGH:
0.9750		ASK:
0.0000		VOLUME:
97
CHG(%):
0.52		PREV:
0.9600		LOW:
0.9650		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Sep 250.97500.97500.96500.965097
02 Sep 251.01001.01000.96000.960097
01 Sep 251.00001.00000.97000.970097
29 Aug 251.01001.01000.93500.935097
28 Aug 250.96000.96000.89500.895097
27 Aug 250.97000.97000.90500.905097
26 Aug 251.01001.01000.93000.930097
25 Aug 250.95500.95500.93500.935097
22 Aug 251.03001.03000.95000.950097
21 Aug 251.04001.04000.91000.910097

COMPANY PROFILE

Name:XTL Biopharmaceuticals Ltd
About:XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. The company has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.
Sector:Healthcare
Industry:Biotechnology
Address:26 Ben-Gurion St., Ramat Gan, Israel, 5112001
Website:https://www.xtlbio.com
ISIN:US98386D3070

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.95
MA10:0.94
MA20:1.01
MA50:1.13
MA100:1.05
MA200:1.23
STO9:51.85
STO14:25.45
RSI14:26.97
WPR14:-64.10
MTM14:-0.13
ROC14:-0.11
ATR:0.08
Week High:1.01
Week Low:0.90
Month High:1.45
Month Low:0.90
Year High:2.46
Year Low:0.77

RECENT SPLITS

Date Ratio
10 Feb 20171-5
04 Oct 20121-10